4th Quarter - Report

FEROX STRATEGIES for AVIDITY BIOSCIENCES, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.

LobbyistCovered position, as disclosed
CRISTINA ANTELO —
DEBRA DIXON —
ZACHARY BENJAMIN FRIEND —
MICHAEL TAGGART —
MARK WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.